Inducible gene expression regulation tool library based on streptomyces gamma-butyric acid lactone signal system and application of inducible gene expression regulation tool library
By constructing a library of inducible gene expression regulation tools based on Streptomyces γ-butyric acid lactone signaling system, the problems of the toxicity and limited use of existing tools are solved, and fine regulation of gene expression and convenient use of tools are achieved.
Patent Information
- Application Number
- CN202411695175.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-25
- Publication Date
- 2025-04-04
AI Technical Summary
Existing gene expression regulation tools, such as IPTG and AHL, have toxicity problems and limited use scope, limiting the development of synthetic biology and medicine.
A library of inducible gene expression regulation tools based on Streptomyces γ-butyric acid lactone signaling system was developed, and fine regulation of gene expression was achieved by constructing a variety of heterozygous promoters and GBL signaling molecular receptors.
It provides a rich promoter library and a variety of inducible gene expression regulation tools, which can be applied in different hosts, avoiding the steps of signal molecules separation and purification, and improving the convenience of the regulation tools.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biotechnology, in particular to an inducible gene expression regulation tool library based on a Streptomyces gamma-butyrolactone signal system and its application. Background Art
[0002] With the development of synthetic biology, various engineered microorganisms have begun to play an increasingly important role in industrial production and disease treatment. In the construction and use of engineered microorganisms, the introduction of gene expression regulation tools has played an important role (reference CR Gurbatri, N. Arpaia, T. Danino, Engineering bacteria as interactive cancer therapies. Science 378, 858-863 (2022). For example, the researchers used cumate ( ρ The authors used a 4-isopropylbenzoic acid (4-isopropylbenzoic acid) induction system to control the temporal expression of acyl-CoA synthase, effectively enhancing the supply of precursors for antibiotic synthesis and further increasing the production of avermectin in the industrial strain Streptomyces avermitilis by 50% to the highest level reported at that time (reference W. Wang et al., Harnessing the intracellular triacylglycerols for titer improvement of polyketidesin Streptomyces . Nat Biotechnol 38, 76-83 (2020)); For example, some scholars genetically modified the probiotic Escherichia coli Nissle 1917 by using IPTG (isopropyl β -D-thiogalactoside, isopropyl- β -D-thiogalactoside) and AHL (acyl-homoserine lactone, acyl homoserine lactone) control the synthesis of engineered bacterial capsule polysaccharides and anticancer drugs, achieving safe and effective treatment of mouse tumors (reference T. Harimoto et al., A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat Biotechnol 40, 1259-1269 (2022)).
[0003] Although gene expression regulation tools represented by IPTG and AHL have achieved great development and application, the lack of new tools still hinders the development of various disciplines such as synthetic biology and medicine. In addition, the inherent shortcomings of existing regulation tools also limit their further transformation and use. For example, IPTG is potentially toxic to the human body. Therefore, in the production process of recombinant drugs, the residue of IPTG will have an adverse effect on the final product, which limits its application in many scenarios (reference G. Hannig, SC Makrides, Strategies for optimizing heterologous protein expression in Escherichia coli . Trends Biotechnol 16, 54-60(1998)); For example, AHL itself is a quorum-sensing signal molecule of many microorganisms, which leads to its main application in non-AHL-producing hosts. In addition, many human intestinal microorganisms can regulate a variety of group behaviors including pathogenicity and motility by producing and responding to AHL, and AHL can also directly affect the immune behavior of the human body (reference RAO Liveira, V. Cabral, I. Torcato, KB Xavier, Deciphering the quorum-sensinglexicon of the gut microbiota. Cell Host Microbe 31, 500-512 (2023)). Therefore, the scope of use of the AHL-induced system is also greatly limited. Therefore, it is necessary to develop new gene expression regulation tools. As the main producer of natural antibiotics, Streptomyces can regulate its own secondary metabolism through its unique quorum sensing signal molecules, among which the most studied is GBL (γ-butyrolactone, γ-butyrolactone) and its quorum sensing effect (reference G. Niu, KF Chater, Y. Tian, J. Zhang, H. Tan, Specialisedmetabolites regulating antibiotic biosynthesis in Streptomyces spp. FEMS Microbiol Rev 40, 554-573 (2016)). Although some scholars have preliminarily proved the feasibility of using the GBL signaling system of Streptomyces as a gene expression regulation tool in the Escherichia coli host, the relevant promoter has not been modified, which limits its further application. Summary of the invention
[0004] The purpose of the present invention is to provide an inducible gene expression regulation tool library based on the Streptomyces gamma-butyrolactone signal system and its application.
[0005] In order to achieve the purpose of the present invention, in a first aspect, the present invention provides an inducible gene expression regulation tool library based on the Streptomyces γ-butyrolactone signal system, the tool library includes 16 kinds of Escherichia coli engineering bacteria, and the construction method thereof includes the following steps: 1) Escherichia coli lacUV5 The LacI-binding sequence on the promoter is replaced with the ArpA-binding sequence to obtain the hybrid promoter ArpA-P, which is used to drive the expression of the target gene to obtain the pArpAP hybrid promoter plasmid①; Escherichia coli lacUV5 The LacI binding sequence on the promoter was replaced with the ScbR binding sequence to obtain the hybrid promoter ScbR-P, which was used to drive the expression of the target gene to obtain the pScbRP hybrid promoter plasmid②; Escherichia coli lacUV5 The LacI binding sequence on the promoter was replaced with the JadR3 binding sequence to obtain the hybrid promoter JadR3-P, which was used to drive the expression of the target gene to obtain the pJadR3P hybrid promoter plasmid③; Escherichia coli lacUV5 The LacI binding sequence on the promoter is replaced with the BarA binding sequence to obtain the hybrid promoter BarA-P, which is used to drive the expression of the target gene to obtain the pBarAP hybrid promoter plasmid④; 2) Use a constitutive promoter to drive arpA Gene expression, obtain pRArpA signal molecule receptor plasmid⑤; use constitutive promoter to drive scbR Gene expression, obtain pRScbR signal molecule receptor plasmid⑥; use constitutive promoter to drive JadR3 Gene expression, obtain pRJadR3 signal molecule receptor plasmid⑦; use constitutive promoter to drive BarA Gene expression, obtain pRBarA signal molecule receptor plasmid⑧; 3) Combine each plasmid in 1) with each plasmid in 2) in pairs, that is, combine plasmid ① with ⑤, ① with ⑥, ① with ⑦, ① with ⑧, combine plasmid ② with ⑤, ② with ⑥, ② with ⑦, ② with ⑧, combine plasmid ③ with ⑤, ③ with ⑥, ③ with ⑦, ③ with ⑧, combine plasmid ④ with ⑤, ④ with ⑥, ④ with ⑦, ④ with ⑧, and introduce the combined plasmids into Escherichia coli together to obtain 16 types of engineered Escherichia coli bacteria.
[0006] In the present invention, the ArpA is Streptomyces griseus ( Streptomyces griseus ) A factor GBL signaling molecule receptor protein ArpA, thearpA The gene encodes the receptor protein ArpA; The ScbR is a Streptomyces coelicolor ( Streptomyces coelicolor ) SCB class GBL signaling molecule receptor protein ScbR, the scbR The gene encodes the receptor protein ScbR; The JadR3 is a Streptomyces venezuelae ( Streptomyces venezuelae ) SVB class GBL signaling molecule receptor protein JadR3, the jadR3 The gene encodes the receptor protein JadR3; The BarA is from Streptomyces virginica ( Streptomyces virginiae ) VB class GBL signaling molecule receptor protein BarA, the barA The gene encodes the receptor protein BarA.
[0007] Furthermore, the target gene includes a reporter gene, such as lux Luminescence gene (GenBank: M90093.1).
[0008] Preferably, the Streptomyces griseus is Streptomyces griseus IFO13350.
[0009] Preferably, the Streptomyces coelicolor is Streptomyces coelicolor M145.
[0010] Preferably, the Streptomyces venezuelae is Streptomyces venezuelae ISP5230.
[0011] Preferably, the Streptomyces virginica is Streptomyces virginica ATCC 13161.
[0012] Preferably, the constitutive promoter is the constitutive promoter P of the tetracycline resistance gene con. (SEQ ID NO: 36).
[0013] Furthermore, the sequence to which ArpA binds is shown in SEQ ID NO: 1; the sequence to which ScbR binds is shown in SEQ ID NO: 2; the sequence to which JadR3 binds is shown in SEQ ID NO: 3; and the sequence to which BarA binds is shown in SEQ ID NO: 4.
[0014] Furthermore, the nucleotide sequences of the hybrid promoters ArpA-P, ScbR-P, JadR3-P and BarA-P are shown in SEQ ID NOs: 17-20, respectively.
[0015] Furthermore, the arpA The nucleotide sequence of the gene is shown in SEQ ID NO: 6; scbRThe nucleotide sequence of the gene is shown in SEQ ID NO: 7; jadR3 The nucleotide sequence of the gene is shown in SEQ ID NO: 8; barA The nucleotide sequence of the gene is shown in SEQ ID NO:9.
[0016] In a specific embodiment of the present invention, the method for constructing the inducible gene expression regulation tool library based on the Streptomyces γ-butyrolactone signal system specifically comprises the following steps: S1. Using primers Pl5F (SEQ ID NO: 10) and Pl5R (SEQ ID NO: 11), the genomic DNA of Escherichia coli BL21 (DE3) was used as a template to amplify the obtained DNA fragment, namely lacUV5 Promoter, through Xho I and Bam After double digestion with HI Xho I and Bam The pCS26-Pac plasmid after HI double restriction digestion was connected to drive the bioluminescent gene cluster lux , and plasmid pLacUV5 was obtained; then, primer pairs Pl5F / Pl5ArpAPR (SEQ ID NO: 13), Pl5F / Pl5ScbRPR (SEQ ID NO: 14), Pl5F / Pl5JadR3PR (SEQ ID NO: 15), and Pl5F / Pl5BarAPR (SEQ ID NO: 16) were used to amplify the obtained DNA fragments, namely, hybrid promoters ArpA-P, ScbR-P, JadR3-P, and BarA-P, respectively, using plasmid pLacUV5 as template. Xho I and Bam After double digestion with HI, Xho I and Bam The pCS26-Pac plasmids after HI double restriction digestion were connected to obtain four hybrid promoter plasmids ①, ②, ③, and ④ respectively; S2, using primers ArpAF (SEQ ID NO: 21) and ArpAR (SEQ ID NO: 22), the genomic DNA of Streptomyces griseus IFO13350 was used as a template to amplify the obtained DNA fragment (SEQ ID NO: 23). Sal After digestion with I Eco RV and Sal I double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con.The A factor signal molecule receptor plasmid pRArpA was obtained by driving expression of the gene. The primers ScbRF (SEQ ID NO: 24) and ScbRR (SEQ ID NO: 25) were used to amplify the DNA fragment (SEQ ID NO: 26) with the genomic DNA of Streptomyces coelicolor M145 as a template. Sal After digestion with I Eco RV and Sal I double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The SCB signal molecule receptor plasmid pRScbR was obtained by driving expression of the SCB signal molecule receptor plasmid; the primers JadR3F (SEQ ID NO: 27) and JadR3R (SEQ ID NO: 28) were used to amplify the genomic DNA of Venezuelan Streptomyces ISP5230 (SEQ ID NO: 29). Bam After HI digestion, Eco RV and Bam HI double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The SVB signal molecule receptor plasmid pRJadR3 was obtained by driving expression of the SVB signal molecule receptor plasmid pRJadR3; the primers BarAF (SEQ ID NO: 30) and BarAR (SEQ ID NO: 31) were used to amplify the DNA fragment (SEQ ID NO: 32) using the genomic DNA of Streptomyces virginica ATCC 13161 as a template. Sal After digestion with I Eco RV and Sal I double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The VB signal molecule receptor plasmid pRBarA was obtained under the driving force of S3. Combine the above hybrid promoter plasmids and signal molecule receptor plasmids in pairs, and transform them into Escherichia coli (such as JM109, purchased from Invitrogen) together.
[0017] In a second aspect, the present invention provides application of the tool library in synthetic biology gene expression regulation.
[0018] Application objects include but are not limited to hosts such as Escherichia coli.
[0019] By means of the above technical solution, the present invention has at least the following advantages and beneficial effects: (i) The hybrid promoter provided by the present invention enriches the promoter library available for synthetic biology; the combinations of different hybrid promoters and different GBL receptors show different degrees of repression, that is, different combinations can obtain different target gene expression intensities, providing resources for synthetic biology related construction.
[0020] (ii) Different GBL signaling molecules have different derepression abilities on different GBL receptors. Their combined use can produce a variety of inducible gene expression regulation tools.
[0021] (III) The present invention can achieve derepression of different GBL receptors through heterologous expression crude extracts of GBL signaling molecules, eliminating the steps of separating and purifying signaling molecules, and facilitating the use of related regulatory tools. This lays the foundation for constructing a variety of autoinducible gene expression regulatory tools based on different GBL signaling systems.
[0022] (IV) The GBL signaling systems discovered so far are mainly concentrated in Streptomyces and are relatively underdeveloped, which provides a broad space for the widespread use of the present invention in other hosts; at the same time, some Streptomyces do not have GBL signaling molecules and there is a certain orthogonality between different GBL signaling systems, which also provides the possibility for the use of the GBL-based inducible gene expression regulation tool constructed by the present invention in Streptomyces. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 The construction and activity detection of GBL-related hybrid promoters in the preferred embodiment of the present invention. A. Principle of hybrid promoter activity detection. B. Activity detection of different promoters at 28 degrees. C. Activity detection of different promoters at 37 degrees. RLU: relative luminescence intensity.
[0024] Figure 2 The expression of GBL signaling molecule receptor and its repressive activity detection on hybrid promoter in the preferred embodiment of the present invention. A. Expression of GBL signaling molecule receptor and its detection principle of repressive activity on hybrid promoter. B. Activity detection of different promoter and receptor protein combinations at 28 degrees. C. Activity detection of different promoter and receptor protein combinations at 37 degrees.
[0025] Figure 3 The derepression ability of GBL signaling molecules on different GBL receptor proteins in the preferred embodiment of the present invention is detected. A. Principle of the derepression ability detection of GBL signaling molecules on different GBL receptor proteins. B. Structures of the four GBL signaling molecules used in the detection. C. Derepression activity detection of different GBL signaling molecules on different GBL receptor proteins.
[0026] Figure 4The heterologous expression of GBL signaling molecules and the detection of the derepression ability of crude extracts on different GBL receptor proteins in the preferred embodiment of the present invention. A. Principle of heterologous expression of GBL signaling molecules. B. Detection of the derepression activity of crude extracts of different GBL signaling molecules on different GBL receptor proteins. DETAILED DESCRIPTION
[0027] The present invention aims to provide an inducible gene expression regulation tool library based on the Streptomyces GBL quorum sensing effect signal system and its application.
[0028] The overall technical scheme of the present invention is to first construct a variety of hybrid promoters so that they can adapt to hosts such as Escherichia coli, effectively drive the expression of target genes, and be regulated (repressed) by corresponding GBL signal molecule receptors; secondly, introduce different GBL signal molecule receptors into hosts such as Escherichia coli so that they can be normally expressed and effectively inhibit the activity of the above hybrid promoters. At the same time, the above different hybrid promoters and signal molecule receptors are combined to characterize their orthogonality; thereafter, different GBL signal molecule synthetic genes are heterologously expressed and extracted by Escherichia coli hosts to obtain corresponding GBL crude extracts, and the transcriptional repression effect of the above GBL receptor protein on the corresponding hybrid promoter is relieved by adding GBL crude extracts or pure products. At the same time, different GBL crude extracts or pure products are added to different GBL receptor and hybrid promoter combinations to characterize their orthogonality.
[0029] The specific technical solution adopted by the present invention is as follows: 1. Construction of GBL-related hybrid promoters: The present invention uses Streptomyces griseus IFO13350 (reference JY Kato, I. Miyahisa, M. Mashiko, Y. Ohnishi, S. Horinouchi, A single target is sufficient to account for the biological effects of the A-factor receptor protein of Streptomyces griseus . J Bacteriol 186, 2206-2211 (2004)) in the target DNA sequence recognized by the A factor-like GBL signaling molecule receptor ArpA (SEQ ID NO: 1), Streptomyces coelicolor M145 (reference NH Hsiao et al., Analysis of two additional signaling moleculesin Streptomyces coelicolorand the development of a butyrolactone-specific reporter system. Chem Biol 16, 951-960 (2009)) is one of the target DNA sequences recognized by the SCB signaling molecule receptor ScbR (SEQ ID NO: 2), Venezuelan Streptomyces ISP5230 (reference Z. Zou et al., Agamma-butyrolactone-sensing activator / repressor, JadR3, controls a regulatory mini-network for jadomycin biosynthesis. Mol Microbiol 94, 490-505 (2014)) and one of the target DNA sequences recognized by the SVB signaling molecule receptor JadR3 (SEQ ID NO: 3) and Streptomyces virginianus ATCC13161 (reference X. Liu et al., A widespread response of Gram-negative bacterialacyl-homoserine lactone receptors to Gram-positive Streptomyces gamma-butyrolactone signaling molecules. Sci China Life Sci 64, 1575-1589 (2021)) in which one of the target sequences recognized by the VB class signal molecule receptor BarA (SEQ ID NO: 4) was replaced by Escherichia coli lacUV5 The target sequence recognized by LacI repressor protein in the promoter (SEQ ID NO: 5) was used to obtain four different hybrid promoters: ArpA-P, ScbR-P, JadR3-P and BarA-P. The activity of the above hybrid promoters was detected by reporter gene (see Figure 1 The promoter involved in the present invention can also be replaced by other different GBL receptor recognition sequences reported in the literature and short DNA sequences with equivalent functions formed by replacing, deleting, or adding one or more base sequences. lacUV5 The target sequence recognized by the LacI repressor protein in the promoter or the above-mentioned GBL receptor recognition sequence is placed between the -10 region and the -35 region of different promoters suitable for different hosts and after the -10 region or the corresponding transcription start site to obtain different hybrid promoters.
[0030] 2. Expression of GBL signal molecule receptors: The present invention uses constitutive promoters to drive the coding sequence of A factor-type GBL signal molecule receptor protein ArpA in Streptomyces griseus IFO13350 (SEQ ID NO: 6), the coding sequence of SCB-type signal molecule receptor protein ScbR in Streptomyces coelicolor M145 (SEQ ID NO: 7), the coding sequence of SVB-type signal molecule receptor protein JadR3 in Streptomyces venezuelae ISP5230 (SEQ ID NO: 8), and the coding sequence of VB-type signal molecule receptor protein BarA in Streptomyces virginiana ATCC13161 (SEQ ID NO: 9), thereby obtaining different recombinant plasmids, and transforming Escherichia coli with the above-mentioned different hybrid promoter plasmids to detect the repression of different GBL receptors on different hybrid promoters (see Figure 2 The present invention also includes different GBL signaling molecule receptor proteins driven by different promoters on different vectors or host genomes.
[0031] 3. Detection of the derepression ability of GBL signal molecules on corresponding receptor proteins: The present invention adds four GBL signal molecule pure products of different concentrations to the above-mentioned Escherichia coli engineered bacteria containing different hybrid promoters and signal molecule receptors to detect their derepression ability on the corresponding GBL receptor proteins (see Figure 3 ). In addition, the present invention obtains crude extracts of A-factor-like GBL signaling molecules in Streptomyces griseus IFO13350, SCB-like signaling molecules in Streptomyces coelicolor M145, SVB-like signaling molecules in Streptomyces venezuelae ISP5230, and VB-like signaling molecules in Streptomyces virginica ATCC13161 by heterologous expression and extraction in Escherichia coli (reference X. Liu et al., A widespread response of Gram-negativebacterial acyl-homoserine lactone receptors to Gram-positive Streptomyces gamma-butyrolactone signaling molecules. Sci China Life Sci 64, 1575-1589 (2021)). The crude extract was added to the Escherichia coli engineered bacteria containing different hybrid promoters and signal molecule receptors to detect its derepression ability of the corresponding GBL receptor protein (see Figure 4 The signal molecule involved in the present invention may also be other types of GBL or structural analogs, as well as crude extracts of the corresponding Streptomyces itself or crude extracts of GBL synthase genes expressed in different heterologous hosts.
[0032] The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are all commercially available products.
[0033] The pCS26-Pac plasmid used in the following examples was obtained from the State Key Laboratory of Microbial Resources Preliminary Development, Institute of Microbiology, Chinese Academy of Sciences (reference K. Tahlan et al., Initiation of actinorhodinexport in Streptomyces coelicolor . Mol Microbiol 63, 951-961 (2007)).
[0034] pACYC184 plasmid was obtained from the State Key Laboratory of Microbial Resources Development, Institute of Microbiology, Chinese Academy of Sciences (reference K. Tahlan et al., Initiation of actinorhodin export in Streptomyces coelicolor . Mol Microbiol 63, 951-961 (2007)).
[0035] Streptomyces griseus IFO13350 used in the following examples was from the State Key Laboratory of Microbial Resources Development, Institute of Microbiology, Chinese Academy of Sciences; Streptomyces coelicolor M145 was from the State Key Laboratory of Microbial Resources Development, Institute of Microbiology, Chinese Academy of Sciences; Streptomyces venezuelae ISP5230 was from the State Key Laboratory of Microbial Resources Development, Institute of Microbiology, Chinese Academy of Sciences; Streptomyces virginica ATCC 13161 was from the State Key Laboratory of Microbial Resources Development, Institute of Microbiology, Chinese Academy of Sciences. (References X. Liu et al., A widespread response of Gram-negative bacterial acyl-homoserine lactone receptors to Gram-positive Streptomyces gamma-butyrolactone signaling molecules. Sci China Life Sci 64, 1575-1589 (2021)) Example 1 Construction and activity detection of GBL-related hybrid promoters Using primers Pl5F (SEQ ID NO: 10) and Pl5R (SEQ ID NO: 11), genomic DNA of Escherichia coli BL21 (DE3) (purchased from Tiangen) was used as a template to amplify a DNA fragment of approximately 0.13 kb (SEQ ID NO: 12). lacUV5 Promoter, through Xho I and Bam After double digestion with HI Xho I and Bam pCS26-Pac plasmid after HI double digestion (reference K. Tahlan et al., Initiation of actinorhodin export in Streptomyces coelicolor . Mol Microbiol 63, 951-961 (2007)) to drive the bioluminescent gene cluster lux , and obtained plasmid pLacUV5; then, primer pairs Pl5F / Pl5ArpAPR (SEQ ID NO: 13), Pl5F / Pl5ScbRPR (SEQ ID NO: 14), Pl5F / Pl5JadR3PR (SEQ ID NO: 15), and Pl5F / Pl5BarAPR (SEQ ID NO: 16) were used to amplify four DNA fragments of approximately 0.13 kb (SEQ ID NOs: 17–20) with plasmid pLacUV5 as template, and four different GBL-related hybrid promoters P hybrid , respectively, after Xho I and Bam After double digestion with HI, Xho I and Bam The pCS26-Pac plasmids were connected after HI double digestion to obtain four different GBL-related hybrid promoter characterization plasmids pArpAP, pScbRP, pJadR3P and pBarAP. The plasmids pLacUV5, pArpAP, pScbRP, pJadR3P, pBarAP and pCS26-Pac (as a control CK) were introduced into Escherichia coli JM109 (purchased from Invitrogen) by chemical transformation to obtain six different engineered bacteria (see Figure 1Finally, the bioluminescence of the above-mentioned engineered bacteria was measured by a plate reader (Gen5 1.10) (reference X. Liu et al., A widespread response of Gram-negative bacterial acyl-homoserine lactone receptors to Gram-positive Streptomyces gamma-butyrolactone signaling molecules. Sci China Life Sci 64, 1575-1589 (2021)). The specific operation is as follows: pick a single colony of the above-mentioned engineered bacteria into a small test tube of 3 mL liquid LB medium containing kanamycin, shake and culture at 37°C, 220 rpm for 8-12 h, then add it to a 96-well plate at a ratio of 1:100 (each well has 200 μL LB medium containing kanamycin), place it in a constant temperature shaker at 220 rpm, and culture it at 28°C or 37°C for 8-12 hours. Detect the luminescence of the sample wells using a plate reader, and compare the relative activities of different promoters by luminescence values. It can be seen that at different culture temperatures (28°C and 37°C), compared with the control (CK), lacUV5 The promoters did not show significant activity, mainly because they were repressed by the E. coli self-repressor protein LacI, while the four modified GBL-related hybrid promoters all showed good activity and the activity levels were comparable, indicating that the LacI protein binding sequence was successfully replaced with the corresponding GBL receptor protein binding sequence without significantly affecting the basic structure of the promoter. These promoters themselves can be used to drive the expression of related genes (see Figure 1 ).
[0036] The formula of LB medium: peptone 10 g / L, yeast extract 5 g / L, sodium chloride 10 g / L, and 1.5% agar added to the solid medium.
[0037] The conditions of the PCR reaction were as follows: DNA polymerase KOD FX (1 U / μL) 1 μL, KOD FX PCR buffer 2×PCR Buffer 25 μL, dNTPs (2 mM each) 10 μL (the above reagents were purchased from TOYOBO, Japan), DMSO (dimethylsulfoxide) 2.5 μL, 10 μM primers 1.5 μL each, template DNA 2.5 μL (10-50 ng), ddH2O 6 μL, total reaction volume 50 μL. PCR cycle conditions: pre-denaturation: 94℃, 5 min; 30 cycles of amplification reaction (94℃ denaturation 30 sec; 55℃ annealing 30 sec; 68℃ extension, 1 kb / min, the specific extension time is determined according to the length of the amplified fragment); full extension 68℃, 5 min; 4℃, storage.
[0038] Example 2 Expression of GBL signaling molecule receptor and detection of its repressive activity on hybrid promoter Using primers ArpAF (SEQ ID NO: 21) and ArpAR (SEQ ID NO: 22), Streptomyces griseus ( Streptomyces griseus ) IFO13350 genomic DNA was used as a template to amplify a DNA fragment (SEQ ID NO: 23) of about 0.96 kb containing the ArpA coding gene and the corresponding sequence of RBS (ribosome binding site). Sal After digestion with I Eco RV and Sal pACYC184 plasmid after double restriction digestion (reference K. Tahlan et al., Initiation of actinorhodin export in Streptomyces coelicolor . Mol Microbiol 63, 951-961(2007)) so that it is linked to the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The expression of factor A GBL receptor protein was obtained by driving the expression of factor A GBL receptor protein plasmid pRArpA; primers ScbRF (SEQ ID NO: 24) and ScbRR (SEQ ID NO: 25) were used to express Streptomyces coelicolor ( S. coelicolor ) M145) genomic DNA was used as a template to amplify a DNA fragment (SEQ ID NO: 26) of approximately 0.74 kb containing the ScbR coding gene and the corresponding sequence of RBS (ribosome binding site). Sal After digestion with I Eco RV and SalI double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The SCB-type GBL receptor protein expression plasmid pRScbR was obtained by driving expression with primers JadR3F (SEQ ID NO: 27) and JadR3R (SEQ ID NO: 28) to express Streptomyces venezuelae ( S. venezuelae ) ISP5230 genomic DNA was used as a template to amplify a 0.81 kb DNA fragment containing the JadR3 coding gene and the RBS (ribosome binding site) corresponding sequence (SEQ ID NO: 29). Bam After HI digestion, Eco RV and Bam HI double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The SVB-type GBL receptor protein expression plasmid pRJadR3 was obtained by driving expression with primers BarAF (SEQ ID NO: 30) and BarAR (SEQ ID NO: 31) to Streptomyces virginica ( S. virginiae ) ATCC 13161 genomic DNA was used as a template to amplify a DNA fragment (SEQ ID NO: 32) of about 0.77 kb containing the BarA coding gene and the corresponding sequence of RBS (ribosome binding site). Sal After digestion with I Eco RV and Sal I double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The VB class GBL receptor protein expression plasmid pRBarA was obtained. The above four different GBL receptor protein expression plasmids and pACYC184 (as a control CK) were combined with the four different GBL-related hybrid promoter characterization plasmids introduced in the examples and introduced into Escherichia coli JM109 by chemical transformation to obtain 20 different engineered bacteria (see Figure 2). Finally, the bioluminescence of the above-mentioned engineered bacteria was determined by a plate reader (see Example 1 for specific operations). By comparing the luminescence values of the co-transformed engineered bacteria of four different GBL receptor protein expression plasmids and the control plasmid pACYC184 and the GBL-related hybrid promoter characterization plasmid, the repressive activity of different GBL receptor proteins on different hybrid promoters was determined. The results show that in addition to the repressive ability of different GBL receptors on their corresponding hybrid promoters, they also have different degrees of repressive activity on other GBL hybrid promoters, indicating that there is a certain degree of interactive regulation between different GBL systems. The combination of different hybrid promoters and different GBL receptor proteins provides an element library for the expression of the target gene (see Figure 2 ) The conditions for the PCR reaction are shown in Example 1.
[0039] Example 3 Detection of the derepression ability of GBL signaling molecules on different GBL receptor proteins Four engineering bacteria co-transformed with different GBL receptor protein expression plasmids and corresponding hybrid promoter characterization plasmids in Example 2 were selected to detect different concentrations of four GBL compounds (SCB1, SCB2, SCB8 and EVB1) (reference X. Liu et al., A widespread response of Gram-negative bacterial acyl-homoserinelactone receptors to Gram-positive Streptomyces gamma-butyrolactone signaling molecules. Sci China Life Sci 64, 1575-1589 (2021)) were used to measure the effects of the engineered bacteria on their bioluminescence. The specific operation was as follows: a single colony of the engineered bacteria was picked into a 3 mL liquid LB medium tube containing kanamycin and chloramphenicol, and cultured at 37°C and 220 rpm for 8–12 h. Then, it was added to a 96-well plate at a ratio of 1:100 (each well had 200 μL of LB medium containing kanamycin, chloramphenicol and four GBL compounds at different concentrations). After being cultured at 28°C or 37°C for 8–12 hours at a constant temperature shaker at 220 rpm, the luminescence of the sample wells was detected by a plate reader. By comparing the recovery of bioluminescence of the engineered bacteria by different GBLs, the derepression ability of different GBLs on different GBL receptor proteins was determined. The results showed that different GBLs exhibited significantly different derepression activities on different GBL receptor proteins, forming a library of inducible gene expression regulation tools (see Figure 3 ).
[0040] In order to enhance the ease of use of the inducible gene expression control tool involved in the present invention, the derepression activity of different GBL heterologous expression crude extracts on different GBL receptor proteins was further explored. First, a heterologous expression plasmid of SVB-type signal molecule synthase was constructed: primers jadW123F (SEQ ID NO: 33) and jadW123R (SEQ ID NO: 34) were used to amplify the three SVB synthesis genes using the genomic DNA of Venezuelan Streptomyces ISP5230 as a template. jadW1 , jadW2 and jadW3 A DNA fragment of about 2.75 kb in size (SEQ ID NO: 35) was assembled by Gibson (reference DG Gibson et al., Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods 6, 343-345 (2009)) and Nde I and Xho The pET23b plasmid (purchased from Novagen) was double-digested with I to obtain plasmid pJADW123, which was then transformed into Escherichia coli C41 (DE3) (purchased from Lucigen) by chemical transformation with the expression plasmids pSGB-AB, pSCB-ACB and pSVB-XS2S1 of factor A, SCB and VB-type GBL synthetic genes, as well as the pET23b plasmid, to obtain five different engineered bacteria: C41 / pJADW123, C41 / pSGB-AB, C41 / pSCB-ACB, C41 / pSVB-XS2S1 and C41 / pET23b. The five strains were induced, extracted and concentrated to obtain crude extracts. The specific operation is as follows: pick a single colony of the above five engineered bacteria into a small test tube of 3 mL liquid LB medium containing ampicillin, culture at 37°C, 220 rpm shaking for 8-12 h, then transfer to 200 mL liquid M9 medium containing ampicillin at an inoculum of 1:100, and culture at 37°C, 220 rpm shaking until OD 600When the pH value was about 0.8–1.2, IPTG was added to a final concentration of 100 μM, and the culture was continued at 28°C with shaking for 72 h. Then, the culture was centrifuged at 4°C and 6000 rpm for 10 minutes, and the supernatant was extracted with an equal volume of ethyl acetate and dried by rotation, and then dissolved with an appropriate amount of DMSO to 1000× (concentrated 1000 times) as a crude GBL extract, of which the crude extract of the engineered bacteria C41 / pET23b was used as the control CK. The four crude extracts were added to the co-transformed engineered bacteria culture system of the above four different GBL receptor protein expression plasmids and the corresponding hybrid promoter characterization plasmids at a ratio of 1‰ (v / v), and the effects on their bioluminescence were detected (see Figure 4 ), the specific method is the same as the detection of the above 4 different GBL compounds.
[0041] The formula of M9 medium: 17.1 g / L disodium hydrogen phosphate dodecahydrate, 3 g / L potassium dihydrogen phosphate, 0.5 g / L sodium chloride, 1 g / L ammonium chloride, 2 mM magnesium sulfate heptahydrate, 0.1 mM calcium chloride, and 4 g / L glucose.
[0042] In summary, the hybrid promoter itself, the combination of different hybrid promoters and different GBL receptor proteins, and the combination of different GBL signaling molecules or crude extracts and different GBL receptor proteins constructed in the present invention provide rich component resources for the construction of gene expression regulatory circuits related to synthetic biology.
[0043] Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements can be made based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention.
Claims
1. An inducible gene expression control tool library based on the Streptomyces γ-butyrolactone signal system, characterized in that: The tool library includes 16 types of Escherichia coli engineered bacteria, and the construction method thereof includes the following steps: 1) Escherichia coli lacUV5 The LacI-binding sequence on the promoter is replaced with the ArpA-binding sequence to obtain the hybrid promoter ArpA-P, which is used to drive the expression of the target gene to obtain the pArpAP hybrid promoter plasmid①; Escherichia coli lacUV5 The LacI binding sequence on the promoter was replaced with the ScbR binding sequence to obtain the hybrid promoter ScbR-P, which was used to drive the expression of the target gene to obtain the pScbRP hybrid promoter plasmid②; Escherichia coli lacUV5 The LacI binding sequence on the promoter was replaced with the JadR3 binding sequence to obtain the hybrid promoter JadR3-P, which was used to drive the expression of the target gene to obtain the pJadR3P hybrid promoter plasmid③; Escherichia coli lacUV5 The LacI binding sequence on the promoter is replaced with the BarA binding sequence to obtain the hybrid promoter BarA-P, which is used to drive the expression of the target gene to obtain the pBarAP hybrid promoter plasmid④; 2) Use a constitutive promoter to drive arpA Gene expression, obtain pRArpA signal molecule receptor plasmid⑤; use constitutive promoter to drive sqR Gene expression, obtain pRScbR signal molecule receptor plasmid⑥; use constitutive promoter to drive jadR3 Gene expression, obtain pRJadR3 signal molecule receptor plasmid⑦; use constitutive promoter to drive barA Gene expression, obtain pRBarA signal molecule receptor plasmid⑧; 3) The plasmids in 1) were combined with the plasmids in 2) in pairs, i.e., plasmids ① and ⑤, ① and ⑥, ① and ⑦, ① and ⑧ were combined; plasmids ② and ⑤, ② and ⑥, ② and ⑦, ② and ⑧ were combined; plasmids ③ and ⑤, ③ and ⑥, ③ and ⑦, ③ and ⑧ were combined; plasmids ④ and ⑤, ④ and ⑥, ④ and ⑦, ④ and ⑧ were combined; and the combined plasmids were introduced into Escherichia coli to obtain 16 kinds of Escherichia coli engineered bacteria respectively; Wherein, the ArpA is Streptomyces griseus ( Streptomyces griseus ) A factor GBL signaling molecule receptor protein ArpA, the arpA The gene encodes the receptor protein ArpA; The ScbR is a Streptomyces coelicolor ( Streptomyces coelicolor ) SCB class GBL signaling molecule receptor protein ScbR, the sqR The gene encodes the receptor protein ScbR; The JadR3 is a Streptomyces venezuelae ( Streptomyces venezuelae ) SVB class GBL signaling molecule receptor protein JadR3, the jadR3 The gene encodes the receptor protein JadR3; The BarA is from Streptomyces virginica ( Streptomyces virginiae ) VB class GBL signaling molecule receptor protein BarA, the barA The gene encodes the receptor protein BarA.
2. The tool library according to claim 1, characterized in that: The target gene includes a reporter gene, preferably lux Luminescent gene; The Streptomyces griseus is Streptomyces griseus IFO13350; The Streptomyces coelicolor is Streptomyces coelicolor M145; The Venezuelan Streptomyces is Venezuelan Streptomyces ISP5230; The Streptomyces virginica is Streptomyces virginica ATCC 13161; The constitutive promoter is the constitutive promoter P of the tetracycline resistance gene. con. .
3. The tool library according to claim 2, characterized in that: The sequence to which ArpA binds is shown in SEQ ID NO: 1; the sequence to which ScbR binds is shown in SEQ ID NO: 2; the sequence to which JadR3 binds is shown in SEQ ID NO: 3; the sequence to which BarA binds is shown in SEQ ID NO: 4; The nucleotide sequences of the hybrid promoters ArpA-P, ScbR-P, JadR3-P, and BarA-P are shown in SEQ ID NOs: 17-20, respectively; Said arpA The nucleotide sequence of the gene is shown in SEQ ID NO: 6; sqR The nucleotide sequence of the gene is shown in SEQ ID NO: 7; jadR3 The nucleotide sequence of the gene is shown in SEQ ID NO: 8; barA The nucleotide sequence of the gene is shown in SEQ ID NO:
9.
4. The tool library according to claim 1, characterized in that: The construction method specifically includes the following steps: S1, using primers P15F and P15R, with Escherichia coli BL21 (DE3) genomic DNA as a template, amplify the obtained DNA fragment, namely lacUV5 Promoter, through XOt I and Bam After double digestion with HI XOt I and Bam The pCS26-Pac plasmid after HI double restriction digestion was connected to drive the bioluminescent gene cluster lux , and plasmid pLacUV5 was obtained; then, primer pairs Pl5F / Pl5ArpAPR, Pl5F / Pl5ScbRPR, Pl5F / Pl5JadR3PR and Pl5F / Pl5BarAPR were used to amplify the obtained DNA fragments, namely the hybrid promoters ArpA-P, ScbR-P, JadR3-P and BarA-P, respectively, with plasmid pLacUV5 as template. XOt I and Bam After double digestion with HI, XOt I and Bam The pCS26-Pac plasmids after HI double restriction digestion were connected to obtain four hybrid promoter plasmids ①, ②, ③, and ④ respectively; S2, using primers ArpAF and ArpAR, the genomic DNA of Streptomyces griseus IFO13350 was used as a template to amplify the obtained DNA fragment. Sal After digestion with I Eco RV and Sal I double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The A factor signal molecule receptor plasmid pRArpA was obtained by driving expression of the factor A signal molecule receptor plasmid pRArpA; the primers ScbRF and ScbRR were used to amplify the DNA fragment with the genomic DNA of Streptomyces coelicolor M145 as the template. Sal After digestion with I Eco RV and Sal I double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The SCB signal molecule receptor plasmid pRScbR was obtained by driving expression of the SCB signal molecule receptor plasmid pRScbR; the primers JadR3F and JadR3R were used to amplify the DNA fragment with the genomic DNA of Venezuelan Streptomyces ISP5230 as the template. Bam After HI digestion, Eco RV and Bam HI double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The SVB signal molecule receptor plasmid pRJadR3 was obtained by driving expression of the SVB signal molecule receptor plasmid pRJadR3; the primers BarAF and BarAR were used to amplify the DNA fragment using the genomic DNA of Streptomyces virginica ATCC 13161 as a template. Sal After digestion with I Eco RV and Sal I double-digested pACYC184 plasmid, so that the constitutive promoter P of the tetracycline resistance gene on the plasmid con. The VB signal molecule receptor plasmid pRBarA was obtained under the driving force of S3, respectively combining the above hybrid promoter plasmids and signal molecule receptor plasmids in pairs, and transforming Escherichia coli together, to obtain; Wherein, the sequences of primers P15F and P15R are shown in SEQ ID NOs: 10 and 11, the sequence of primer P15ArpAPR is shown in SEQ ID NO: 13, the sequence of primer P15ScbRPR is shown in SEQ ID NO: 14, the sequence of primer P15JadR3PR is shown in SEQ ID NO: 15, and the sequence of primer P15BarAPR is shown in SEQ ID NO: 16; The sequences of primers ArpAF and ArpAR are shown in SEQ ID NOs: 21 and 22, the sequences of primers ScbRF and ScbRR are shown in SEQ ID NOs: 24 and 25, the sequences of primers JadR3F and JadR3R are shown in SEQ ID NOs: 27 and 28, and the sequences of primers BarAF and BarAR are shown in SEQ ID NOs: 30 and 31.
5. Use of the tool library according to any one of claims 1 to 4 in synthetic biology gene expression regulation.
6. The method according to claim 5, characterized in that Application targets include Escherichia coli.
